Since no device has been received for analysis, no product investigation can be performed, and the customer complaint cannot be confirmed.A manufacturing record evaluation was performed for the finished device lot# 30342323m, and no internal actions related to the complaint was found during the review.If additional information is received regarding this event, a supplemental 3500a report will be submitted to the fda.(b)(4).
|
It was reported that a patient underwent ischemic ventircular tachycardia (isvt) ablation procedure with thermocool® smart touch® sf bi-directional navigation catheter and suffered cardiac tamponade requiring surgical intervention.Toward the end of the procedure epicardial access was obtained, with intent of ablating epicardially, and it was at that point that the effusion was diagnosed.A pericardiocentesis was performed and the patient was in route to the operation room (or) at the time of the call.The physician believed the effusion occurred when the coronary sinus (cs) was cannulated or during ablation within the cs.It was undetermined whether the physician believed that biosense webster products contributed toward the patient event or not.There was no report of extended hospitalization.Multiple attempts have been made to obtain clarification to this complaint.However, no further information has been made available.Should more information become available in the future; the reportability decision will be reassessed.
|
On(b)(6)2020 , the complaint device was received for evaluation.On (b)(6)2020 , the product investigation was completed.It was reported that a patient underwent ischemic ventircular tachycardia (isvt) ablation procedure with thermocool® smart touch® sf bi-directional navigation catheter and suffered cardiac tamponade requiring surgical intervention.Toward the end of the procedure epicardial access was obtained, with intent of ablating epicardially, and it was at that point that the effusion was diagnosed.A pericardiocentesis was performed and the patient was in route to the operation room (or) at the time of the call.The physician believed the effusion occurred when the coronary sinus (cs) was cannulated or during ablation within the cs.It was undetermined whether the physician believed that biosense webster products contributed toward the patient event or not.There was no report of extended hospitalization.Device evaluation details: the device was visually inspected, and it was found in good normal conditions.The magnetic, temperature and force features were tested, and no issues were observed.In addition, the catheter was deflecting and irrigating correctly.A manufacturing record evaluation was performed, and no internal actions related to the reported complaint were identified.The catheter passed all specifications.The root cause of the adverse event remains unknown.The instructions for use states that careful catheter manipulation must be performed to avoid cardiac damage, perforation or tamponade.The catheter passed specification.If additional information is received regarding this event, a supplemental 3500a report will be submitted to the fda.Manufacturer's reference number: pc-000723442.
|